Cost-effectiveness (CE) analysis of interferon-alpha in high-risk melanoma patients

被引：1
|
作者：
Ding, M
Xing, Y
Shih, T
Cox, D
Cantor, S
Cormier, J
机构：
[1] Rice Univ, Houston, TX 77251 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62070-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：221 / 221
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of interferon for high-risk (stage III) melanoma patients
    Guillem, V
    Alvarez-Mon, M
    Camacho, F
    Diaz-Perez, JL
    Diaz-Rubio, E
    Gonzalez-Larriba, JL
    Lopez-Lopez, JJ
    Moreno, JA
    Serrano, S
    Toribio, J
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S372 - S372
  • [2] Cost-effectiveness analysis of interferon as adjuvant therapy in high-risk melanoma patients in Spain
    González-Larriba, JL
    Serrano, S
    Alvarez-Mon, M
    Camacho, F
    Casado, MA
    Díaz-Pérez, JL
    Díaz-Rubio, E
    Fosbrook, L
    Guillem, V
    López-López, JJ
    Moreno-Nogueira, JA
    Toribio, J
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 (18) : 2344 - 2352
  • [3] A retrospective cost-effectiveness analysis of interferon as adjuvant therapy in high-risk resected cutaneous melanoma
    Messori, A
    Becagli, P
    Trippoli, S
    Tendi, E
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (09) : 1373 - 1379
  • [4] Influence of pegylated interferon-alpha on the nitric oxide system in high-risk melanoma patients
    Fekkes, D
    Bannink, M
    Kruit, WHJ
    Sleijfer, S
    Mulder, PGH
    Eggermont, AMM
    Stoter, G
    Van Gool, AR
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S408 - S408
  • [5] Quality of life and cost-effectiveness of interferon-alpha in malignant melanoma: results from randomised trial
    Dixon, S
    Walters, SJ
    Turner, L
    Hancock, BW
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (04) : 492 - 498
  • [6] Quality of life and cost-effectiveness of interferon-alpha in malignant melanoma: results from randomised trial
    S Dixon
    S J Walters
    L Turner
    B W Hancock
    [J]. British Journal of Cancer, 2006, 94 : 492 - 498
  • [7] Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha
    Desai, HG
    [J]. NATIONAL MEDICAL JOURNAL OF INDIA, 2003, 16 (03): : 175 - 175
  • [8] Cost-effectiveness of ipilimumab versus high-dose interferon as an adjuvant therapy in resected high-risk melanoma
    Salans, Mia
    Courtney, Patrick Travis
    Yip, Anthony
    Murphy, James D.
    [J]. CANCER MEDICINE, 2021, 10 (19): : 6618 - 6626
  • [9] Cost-effectiveness of human interferon-alpha as adjuvant treatment for patients with resected cutaneous malignant melanoma in stage IIB & III
    Kasteng, F.
    Stadler, R.
    Wagenius, G.
    Lundkvist, J.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A330 - A330
  • [10] Adjuvant Interferon-Alpha Treatment for High-Risk Melanoma Patients: A Single Tertiary Care Center Experience
    Allen, K.
    Graham, N.
    Godbout, L.
    Young, V
    Verma, S.
    Song, X.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 61 - 61
12345